Skip to content
CancerIndex

Publication

Evaluation of Progression-Free Survival as a Surrogate Endpoint for Overall Survival in Localized Pancreatic Cancer: Trans-Atlantic Pancreatic Surgery Consortium Study.

Jun Okui, Marc G Besselink, Alice C Wei, Eileen M O'Reilly, Bas Groot Koerkamp, Sebastiaan Ceuppens, Esther N Dekker, Alessandro Paniccia, Amer H Zureikat, Ching-Wei D Tzeng, Matthew H G Katz, Naruhiko Ikoma, Trans-Atlantic Pancreatic Surgery (TAPS) Consortium

Annals of surgical oncologySep 26, 2026PMID 42791489doi:10.1245/s10434-026-20620-5 Journal ArticlepubmedProvenance
Source
PubMed
Retrieved
Sep 30, 2026
Layer
normalized (units and labels harmonized; values unchanged)
Run
ING-PUBMED-20260930-000001
Published

Abstract

Abstract (excerpt)

Only the opening of the abstract is shown; abstract text may carry publisher copyright.

BACKGROUND: Overall survival (OS) is considered the reference-standard endpoint for assessing treatment efficacy in oncology but requires prolonged follow-up evaluation. This study assessed progression-free survival (PFS) as a surrogate endpoint for OS in patients with localized pancreatic ductal…

Read on PubMed

Linked entities

Linked entities (1)

How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.

Candidate 1

Curated evidence

Evidence citing this paper (0)

Data not yet available

No curated evidence item cites this publication.